home / stock / aqs:cc / aqs:cc quote
Last: | $0.065 |
---|---|
Change Percent: | -13.33% |
Open: | $0.07 |
Close: | $0.065 |
High: | $0.07 |
Low: | $0.065 |
Volume: | 14,501 |
Last Trade Date Time: | 05/06/2022 04:55:12 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.065 | $0.07 | $0.065 | $0.07 | $0.065 | 14,501 | 05-06-2022 |
$0.075 | $0.075 | $0.075 | $0.075 | $0.075 | 6,461 | 05-05-2022 |
$0.065 | $0.07 | $0.065 | $0.075 | $0.065 | 81,929 | 05-03-2022 |
$0.07 | $0.07 | $0.07 | $0.07 | $0.065 | 66,097 | 05-02-2022 |
$0.065 | $0.065 | $0.065 | $0.065 | $0.065 | 51,002 | 04-28-2022 |
$0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 2,715 | 04-27-2022 |
$0.075 | $0.07 | $0.075 | $0.075 | $0.07 | 88,350 | 04-26-2022 |
$0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 68,002 | 04-25-2022 |
$0.075 | $0.075 | $0.075 | $0.075 | $0.075 | 5,000 | 04-22-2022 |
$0.07 | $0.075 | $0.07 | $0.075 | $0.07 | 21,026 | 04-21-2022 |
$0.08 | $0.08 | $0.08 | $0.08 | $0.075 | 114,500 | 04-20-2022 |
$0.08 | $0.08 | $0.08 | $0.08 | $0.08 | 37,505 | 04-19-2022 |
$0.075 | $0.08 | $0.075 | $0.08 | $0.075 | 4,516 | 04-15-2022 |
$0.075 | $0.08 | $0.075 | $0.08 | $0.075 | 4,516 | 04-14-2022 |
$0.075 | $0.08 | $0.075 | $0.08 | $0.075 | 172,000 | 04-13-2022 |
$0.08 | $0.08 | $0.08 | $0.08 | $0.08 | 10,000 | 04-12-2022 |
$0.08 | $0.08 | $0.08 | $0.08 | $0.08 | 25,111 | 04-11-2022 |
$0.08 | $0.075 | $0.08 | $0.08 | $0.075 | 209,598 | 04-08-2022 |
$0.08 | $0.08 | $0.08 | $0.08 | $0.075 | 98,522 | 04-06-2022 |
$0.075 | $0.075 | $0.075 | $0.075 | $0.075 | 37,513 | 04-05-2022 |
News, Short Squeeze, Breakout and More Instantly...
Aequus Pharmaceuticals Inc. Company Name:
AQS:CC Stock Symbol:
TSXVC Market:
Aequus Pharmaceuticals Inc. (AQS:CA) is expected to report for Q1 2024
(TheNewswire) VANCOUVER, May 09, 2024 – TheNewswire – Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company focused on bringing healthcare solutions to Canadians through licens...
(TheNewswire) VANCOUVER, BC. May 7, 2024 – TheNewswire – Aequus Pharmaceuticals Inc. (TSX-V: AQS , OTCQB: AQSZF ), ) (“Aequus” or the “Company”), a specialty pharmaceutical company, in resp...